KLOW Tissue Repair Peptide Blend (GHK-Cu · BPC-157 · TB-500 · KPV) — Scientific Guide
KLOW is a research blend combining four repair peptides in a single vial: GHK-Cu, BPC-157, TB-500 and KPV. A formulation designed to study tissue regeneration through a multi-pathway approach — angiogenesis, cell migration, matrix synthesis and modulation of inflammation.
What is KLOW?
KLOW is a research peptide blend combining four peptides with complementary repair and regeneration properties in a single vial. Its name is derived from GLOW, to which it adds KPV, and it contains 80 mg of active peptides distributed as follows: GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 / Thymosin Beta-4 (10 mg) and KPV (10 mg).
The scientific interest of KLOW lies not in a single mechanism but in the convergence of four distinct tissue repair pathways. Whereas an isolated peptide acts on a precise lever, the blend allows the study of the effect of simultaneous stimulation of angiogenesis, cell migration, collagen synthesis, and inflammatory modulation.
Unlike an isolated peptide such as BPC-157 or TB-500, KLOW is a fixed combination of four molecules. This means that the components share the same solvent and reconstitution kinetics, but they cannot be dosed independently of each other. It is a format designed for research on multi-pathway systemic repair.
Blend composition
| Component | Dose | Main role in research |
|---|---|---|
| GHK-Cu | 50 mg | Copper tripeptide — collagen synthesis, angiogenesis, extracellular matrix remodeling |
| BPC-157 | 10 mg | Stable gastric peptide — repair of tendons, ligaments, muscles and mucous membranes |
| TB-500 | 10 mg | Thymosin Beta-4 fragment — actin regulation, cell migration, wound healing |
| KPV | 10 mg | α-MSH derived tripeptide — anti-inflammatory and soothing properties |
Mechanisms of action
The strength of KLOW lies in the complementarity of its four components, which act on distinct but convergent pathways of tissue repair.
Angiogenesis and vascularization
GHK-Cu and BPC-157 stimulate the formation of new blood vessels, notably through the expression of VEGF (Vascular Endothelial Growth Factor). TB-500 enhances this pathway by promoting the migration and proliferation of endothelial cells. The objective of this study is to improve the supply of oxygen and nutrients to damaged tissues—a step that is often critical for wound healing.
Cell migration and proliferation
TB-500 regulates G-actin polymerization, facilitating the migration of repair cells (fibroblasts, keratinocytes, endothelial cells) to damaged areas. This cell mobility is a prerequisite for granulation tissue formation and wound closure.
Matrix synthesis and collagen
GHK-Cu activates fibroblasts and stimulates the production of collagen (types I and III), elastin, and glycosaminoglycans. It is this property that makes it one of the most studied peptides for the quality of the reconstructed extracellular matrix, and not simply the speed of wound closure.
Modulation of inflammation
KPV inhibits pro-inflammatory pathways (notably NF-κB) and reduces cytokine production. In a repair-oriented blend, its function is to maintain inflammation within a physiological window: sufficient to initiate repair, but limited to prevent chronic tissue damage.
Synergy of the four components
The research hypothesis behind KLOW is that these four peptides together cover most of the steps in the tissue repair cascade, whereas each one taken in isolation only covers a part of it.
Structural pathways
- GHK-Cu → collagen & matrix
- GHK-Cu + BPC-157 → angiogenesis (VEGF)
- TB-500 → cell migration
- BPC-157 → tendons & ligaments
Regulatory pathways
- KPV → anti-inflammatory (NF-κB)
- BPC-157 → NO system modulation
- TB-500 → cytokine reduction
- GHK-Cu → tissue remodeling
KLOW Technical Specifications
| Property | Value |
|---|---|
| Total composition | 80 mg (GHK-Cu 50 / BPC-157 10 / TB-500 10 / KPV 10) |
| Form | Lyophilized powder in a single vial |
| Analysis | Janoshik Report #223511, four peptides measured separately (97.33 mg measured) |
| Recommended solvent | Bacteriostatic Water USP |
| Freeze-dried preservation | 12-24 months at -20°C |
| Reconstructed conservation | ~28 days at 2-8°C (BAC water) |
Reconstitution and manipulation in research
KLOW is reconstituted like a standard lyophilized peptide, using bacteriostatic water. The volume of solvent is chosen according to the desired working concentration: a larger volume facilitates the preparation of small doses but dilutes the solution. Since the flask must remain intact, dissolution is carried out by letting the water run down the side of the flask without vigorous shaking, to preserve the peptides.
Since the blend is a fixed combination, the ratio between the four components remains constant regardless of the sample: GHK-Cu cannot be isolated from BPC-157, for example. For protocols requiring independent measurement of a component, isolated peptides remain the appropriate format.
Limitations and state of research
As with its components taken separately, the available data on KLOW and its peptides are almost exclusively preclinical (rodents, cell models):
- Lack of large-scale randomized clinical trials on the blend as such
- The data come primarily from studies on each isolated peptide, and not on their fixed combination.
- The pharmacokinetic interactions between the four components administered together remain poorly characterized.
- Pro-angiogenic mechanisms theoretically to be monitored in neoplastic contexts
KLOW research available at MyPeptide
Blend 80 mg (GHK-Cu · BPC-157 · TB-500 · KPV) peptide-by-peptide quantified by Janoshik. Lyophilized at -20°C. Ships from the EU in 2 to 5 business days.
🧪 Research Peptides — Europe Delivery
Four peptides measured by Janoshik · Verifiable report · Discreet shipping in 2 to 5 business days
🇫🇷 Retatrutide France ·
🇧🇪 Belgium ·
🇩🇪 Germany ·
🇪🇸 Spain ·
🇮🇹 Italy
🇫🇷 GHK-Cu France ·
🇧🇪 Belgium ·
🇩🇪 Germany ·
🇪🇸 Spain ·
→ All countries
📚 Scientific reference:
Pickart L, Margolina A. “Regenerative and Protective Actions of the GHK-Cu Peptide. » Int J Mol Sci. 2018.
PubMed PMID:29986520 →

